TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus

Go back to TP-03 (lotilaner ophthalmic solution) 0.25% Now Approved in China for the Treatment of Demodex Blepharitis, Triggering a $15M Milestone Payment to Tarsus
(NASDAQ: TARS) Delayed: 63.56 +0.40 (0.63%)
Previous Close $63.16    52 Week High
Open $63.34    52 Week Low
Day High $64.21    P/E N/A 
Day Low $62.51    EPS
Volume 788,704